Clinical trials recruiting for Leptomeningeal Metastases
Fewer than 3 recruiting trials found.
2
Recruiting trials
0
US states with sites
1
Countries
0%
Accept healthy volunteers
Phase breakdown
Phase 1 1Phase 2 2
Drugs and treatments being studied
| Intervention | Trials |
|---|---|
| Pemetrexed | 1 |
| Sacituzumab govitecan | 1 |
| The treatment regimen is Furmonertinib combined with Bevacizumab. | 1 |
Self-screener
Recruiting trials
- Evaluation of the Efficacy and Safety of Furmonertinib Combined with Bevacizumab As First-Line Treatment for EGFR-Positive Non-Small Cell Lung Cancer with Brain Metastases: a Single-Arm, Open-Label, Prospective Phase II Clinical Study
- Sacituzumab Govitecan and Intrathecal Chemotherapy for Treating Leptomeningeal Metastases From Her2-negative Breast Cancer
Related conditions
Trials recruiting for Leptomeningeal Metastases often also study these conditions. Each links to its own recruiting-trial list.
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Leptomeningeal Metastases trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.